Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisNEJM 376:209-220,280, Montalban, X.,et al, 2017
Neurologic Complications of the Reactivation of Varicella-Zoster VirusNEJM 342:635-645, Gilden,D.H.,et al, 2000